Since late December 2006, the informal investors group Business Angels Technostarters (BAT), is involved in NSure as financer of the start-up phase.
The financial support by BAT enables NSure to make a flying start. NSure will now be able to commence with the market introduction of newly developed assays at an accelerated pace. Ton van Berkel, partner in BAT, has confidence in the future co-operation: “NSure combines unique (patented) knowledge with a very enthusiastic and experienced team: therefore we expect the chances for success to be high.” Wageningen University and Research Centre was already involved in NSure as financer.
Wageningen University and Research Centre was already involved in NSure as financer.